Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study.

Saved in:
Bibliographic Details
Title: Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study.
Authors: Hohnloser SH; Division Clinical Electrophysiology, Department of Cardiology, Johann Wolfgang Goethe University, Frankfurt, Germany. Hohnloser@em.uni-frankfurt.de., Basic E; Pfizer Deutschland GmbH, Berlin, Germany., Nabauer M; Department of Cardiology, Ludwig Maximilians University, Munich, Germany.
Source: Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2017 Aug; Vol. 106 (8), pp. 618-628. Date of Electronic Publication: 2017 Mar 14.
Publication Type: Clinical Trial; Journal Article; Multicenter Study
Journal Info: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 101264123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0692 (Electronic) Linking ISSN: 18610684 NLM ISO Abbreviation: Clin Res Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1861-0692
DOI:10.1007/s00392-017-1098-x